Zevra Therapeutics, Inc. (ZVRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 4.8100 |
| Open | 4.8500 |
| Bid | 3.5600 x 200 |
| Ask | 4.9300 x 100 |
| Day's range | 4.7408 - 4.9400 |
| 52-week range | 3.8900 - 7.2800 |
| Volume | |
| Avg. volume | 225,928 |
| Market cap | 205.082M |
| Beta (5Y monthly) | 1.96 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Breakeven On The Horizon For Zevra Therapeutics, Inc. (NASDAQ:ZVRA)
We feel now is a pretty good time to analyse Zevra Therapeutics, Inc.'s ( NASDAQ:ZVRA ) business as it appears the...
- Simply Wall St.
Retail investors account for 59% of Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) ownership, while institutions account for 28%
Key Insights Significant control over Zevra Therapeutics by retail investors implies that the general public has more...
- Insider Monkey
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2024 Earnings Call Transcript May 8, 2024 Zevra Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone. Thank you for joining the Zevra Therapeutics’ First Quarter 2024 Corporate Update and Financial […]
© 2024 Yahoo. All rights reserved.